tiprankstipranks
Sihuan Pharmaceutical Holdings Group Ltd. (HK:0460)
:0460
Hong Kong Market
0460
Sihuan Pharmaceutical Holdings Group
RESEARCH TOOLSreports
Want to see HK:0460 full AI Analyst Report?

Sihuan Pharmaceutical Holdings Group (0460) Income Statement

1 Followers

Sihuan Pharmaceutical Holdings Group Income Statement

Last quarter (Q4 2025), Sihuan Pharmaceutical Holdings Group's total revenue was ¥1.47B, an increase of 82.87% from the same quarter last year. In Q4, Sihuan Pharmaceutical Holdings Group's net income was ¥77.09M. See Sihuan Pharmaceutical Holdings Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 2.62B¥ 1.90B¥ 1.86B¥ 2.18B¥ 3.04B
Gross Profit
¥ 1.80B¥ 1.24B¥ 1.30B¥ 1.49B¥ 2.43B
Operating Expenses
¥ 1.19B¥ 1.38B¥ 1.13B¥ 3.32B¥ 1.66B
Depreciation and Amortization
¥ 165.89M¥ 180.75M¥ 226.23M¥ 369.81M¥ 255.49M
EBITDA
¥ 642.61M¥ -208.66M¥ 334.31M¥ -1.54B¥ 931.69M
Operating Income
¥ 607.12M¥ -138.13M¥ 161.70M¥ -1.83B¥ 771.95M
Other Income/Expenses
¥ -189.97M¥ -290.16M¥ -322.96M¥ -292.05M¥ -275.93M
Pretax Income
¥ 417.16M¥ -428.29M¥ -161.26M¥ -2.12B¥ 496.01M
Net Income
¥ 179.70M¥ -216.66M¥ -54.02M¥ -1.91B¥ 416.51M
Per Share Metrics
Basic EPS
¥ 0.02¥ -0.02¥ -0.01¥ -0.21¥ 0.04
Diluted EPS
¥ 0.02¥ -0.02¥ -0.01¥ -0.21¥ 0.04
Weighted Average Shares Outstanding
 9.12B 9.27B 9.30B 9.33B 9.43B
Weighted Average Shares Outstanding (Diluted)
 9.13B 9.27B 9.30B 9.33B 9.48B
Currency in CNY

Sihuan Pharmaceutical Holdings Group Earnings and Revenue History